4.7 Article

Serogroup W135 Meningococcal Disease, The Gambia, 2012

Journal

EMERGING INFECTIOUS DISEASES
Volume 19, Issue 9, Pages 1507-1510

Publisher

CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid1909.130077

Keywords

-

Funding

  1. Medical Research Council
  2. Bill & Melinda Gates Foundation
  3. MRC [MC_EX_MR/K011944/1, MC_UP_A900_1116, MC_UP_1003/1, MC_UP_A900_1122, MC_UP_A900_1119] Funding Source: UKRI
  4. Medical Research Council [MC_UP_1003/1, MC_UP_A900_1119, MC_EX_MR/K011944/1, MC_UP_A900_1122, MC_UP_A900_1116] Funding Source: researchfish

Ask authors/readers for more resources

In 2012, an outbreak of Neisseria meningitidis serogroup W135 occurred in The Gambia. The attack rate was highest among young children. The associated risk factors were male sex, contact with meningitis patients, and difficult breathing. Enhanced surveillance facilitates early epidemic detection, and multiserogroup conjugate vaccine could reduce meningococcal epidemics in The Gambia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available